Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huseyin Akilli

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 29, 2020
Nulliparity and postmenopausal status are independent factors of malignancy potential of endometrial intraepithelial neoplasia in polypsLatife Atasoy Karakas, Alev Ok Atilgan, Huseyin Akilli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2021
Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemicAli Ayhan, Safak Yilmaz Baran, Dogan Vatansever, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 5, 2020
Comparison of no adjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factorsHuseyin Akilli, Yusuf A Tohma, Ayça N Bulut, et al.
Clinical Transplantation|June 1, 2018
Possible impact of immunosuppressive therapy regimens on histopathologic outcomes of abnormal uterine bleeding in solid-organ transplant recipientsYusuf Aytac Tohma, Huseyin Akilli, Mahir Kirnap, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group StudyUtku Akgör, Derman Basaran, Mehmet Mutlu Meydanli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 5, 2024
Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group StudyUtku Akgör, Derman Basaran, Mehmet Mutlu Meydanli, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|October 27, 2021
The safety of major gynaecologic cancer surgery without routine preoperative COVID-19 testing in the COVID-19 era: a multicentre, retrospective, case-control studyMurat Oz, Mehmet Mutlu Meydanli, Mufide Iclal Altintas, et al.
Journal of Clinical Medicine|December 30, 2025
Retrospective Multicenter Analysis of Malignant Struma Ovarii: Clinical Characteristics, Management, and OutcomesAtacem Mert Aytekin, Yagmur Arslan, Utku Akgor, et al.
The Journal of Obstetrics and Gynaecology Research|January 11, 2021
Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?Zeliha Firat Cuylan, Huseyin Akilli, Kemal Gungorduk, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2019
SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter studyIlker Kahramanoglu, Mehmet Mutlu Meydanli, Siarhei Taranenka, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 29, 2020
Nulliparity and postmenopausal status are independent factors of malignancy potential of endometrial intraepithelial neoplasia in polypsLatife Atasoy Karakas, Alev Ok Atilgan, Huseyin Akilli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2021
Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemicAli Ayhan, Safak Yilmaz Baran, Dogan Vatansever, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 5, 2020
Comparison of no adjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factorsHuseyin Akilli, Yusuf A Tohma, Ayça N Bulut, et al.
Clinical Transplantation|June 1, 2018
Possible impact of immunosuppressive therapy regimens on histopathologic outcomes of abnormal uterine bleeding in solid-organ transplant recipientsYusuf Aytac Tohma, Huseyin Akilli, Mahir Kirnap, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group StudyUtku Akgör, Derman Basaran, Mehmet Mutlu Meydanli, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 5, 2024
Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group StudyUtku Akgör, Derman Basaran, Mehmet Mutlu Meydanli, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|October 27, 2021
The safety of major gynaecologic cancer surgery without routine preoperative COVID-19 testing in the COVID-19 era: a multicentre, retrospective, case-control studyMurat Oz, Mehmet Mutlu Meydanli, Mufide Iclal Altintas, et al.
Journal of Clinical Medicine|December 30, 2025
Retrospective Multicenter Analysis of Malignant Struma Ovarii: Clinical Characteristics, Management, and OutcomesAtacem Mert Aytekin, Yagmur Arslan, Utku Akgor, et al.
The Journal of Obstetrics and Gynaecology Research|January 11, 2021
Is the extent of lymphadenectomy a prognostic factor in International Federation of Gynecology and Obstetrics stage II endometrioid endometrial cancer?Zeliha Firat Cuylan, Huseyin Akilli, Kemal Gungorduk, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 5, 2019
SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter studyIlker Kahramanoglu, Mehmet Mutlu Meydanli, Siarhei Taranenka, et al.
Pageof 3